GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » PURE Bioscience Inc (OTCPK:PURE) » Definitions » E10

PURE Bioscience (PURE Bioscience) E10 : $-0.13 (As of Jan. 2024)


View and export this data going back to 1996. Start your Free Trial

What is PURE Bioscience E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PURE Bioscience's adjusted earnings per share data for the three months ended in Jan. 2024 was $-0.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.13 for the trailing ten years ended in Jan. 2024.

During the past 3 years, the average E10 Growth Rate was 34.70% per year. During the past 5 years, the average E10 Growth Rate was 30.30% per year. During the past 10 years, the average E10 Growth Rate was 20.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of PURE Bioscience was 34.70% per year. The lowest was 3.00% per year. And the median was 8.70% per year.

As of today (2024-06-11), PURE Bioscience's current stock price is $0.0899. PURE Bioscience's E10 for the quarter that ended in Jan. 2024 was $-0.13. PURE Bioscience's Shiller PE Ratio of today is .


PURE Bioscience E10 Historical Data

The historical data trend for PURE Bioscience's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PURE Bioscience E10 Chart

PURE Bioscience Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.80 -0.61 -0.42 -0.25 -0.17

PURE Bioscience Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 -0.19 -0.17 -0.15 -0.13

Competitive Comparison of PURE Bioscience's E10

For the Household & Personal Products subindustry, PURE Bioscience's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PURE Bioscience's Shiller PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PURE Bioscience's Shiller PE Ratio falls into.



PURE Bioscience E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PURE Bioscience's adjusted earnings per share data for the three months ended in Jan. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=-0.01/130.1244*130.1244
=-0.010

Current CPI (Jan. 2024) = 130.1244.

PURE Bioscience Quarterly Data

per share eps CPI Adj_EPS
201404 -0.070 100.023 -0.091
201407 -0.090 100.520 -0.117
201410 -0.050 100.176 -0.065
201501 -0.040 98.604 -0.053
201504 -0.050 99.824 -0.065
201507 -0.040 100.691 -0.052
201510 -0.070 100.346 -0.091
201601 -0.190 99.957 -0.247
201604 -0.020 100.947 -0.026
201607 -0.010 101.524 -0.013
201610 -0.030 101.988 -0.038
201701 -0.010 102.456 -0.013
201704 -0.030 103.167 -0.038
201707 -0.030 103.278 -0.038
201710 -0.040 104.070 -0.050
201801 -0.030 104.578 -0.037
201804 -0.020 105.708 -0.025
201807 -0.020 106.324 -0.024
201810 -0.040 106.695 -0.049
201901 -0.020 106.200 -0.025
201904 -0.030 107.818 -0.036
201907 -0.010 108.250 -0.012
201910 -0.010 108.577 -0.012
202001 -0.010 108.841 -0.012
202004 0.010 108.173 0.012
202007 0.020 109.318 0.024
202010 -0.002 109.861 -0.002
202101 -0.010 110.364 -0.012
202104 -0.010 112.673 -0.012
202107 -0.010 115.183 -0.011
202110 -0.010 116.696 -0.011
202201 -0.010 118.619 -0.011
202204 -0.010 121.978 -0.011
202207 -0.010 125.002 -0.010
202210 -0.010 125.734 -0.010
202301 -0.010 126.223 -0.010
202304 -0.010 127.992 -0.010
202307 -0.010 128.974 -0.010
202310 -0.010 129.810 -0.010
202401 -0.010 130.124 -0.010

Add all the adjusted EPS together and divide 10 will get our e10.


PURE Bioscience  (OTCPK:PURE) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PURE Bioscience E10 Related Terms

Thank you for viewing the detailed overview of PURE Bioscience's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


PURE Bioscience (PURE Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
771 Jamacha Road, No. 512, El Cajon, CA, USA, 92019
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, products preserved with SDC and SDC as a raw material ingredient for manufacturing use.
Executives
Robert F Bartlett director 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Bernard Blotner director 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Tom Y Lee director 1807 SAN GABRIEL BLVD., SAN GABRIEL CA 91776
David Rendall director 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Kristin Taylor director 13500 EVENING CREEK DRIVE N, SUITE 550, SAN DIEGO CA 92128
Dale Okuno director 35 N. ARROYO PARKWAY, SUITE 1, PASADENA CA 91103
Ivan Chen director 1725 GILLESPIE WAY, EL CAJON CA 92020
Thomas Richard Myers officer: Chief Operating Officer 1725 GILLESPIE WAY, EL CAJON CA 92130
Henry R. Lambert director, officer: Chief Executive Officer 1725 GILLESPIE WAY, EL CAJON CA 92020
Elisabeth Hagen director 1725 GILLESPIE WAY, EL CAJON CA 92020
Janet Risi Field director 9200 SOUTH DADELAND BOULEVARD, SUITE 800, MIAMI FL 33156
Franchise Brands, Llc 10 percent owner 325 BIC DRIVE, MILFORD CT 06461
Mark Stuart Elliott officer: Vice President, Finance 1725 GILLESPIE WAY, EL CAJON CA 92020
William Otis director 1725 GILLESPIE WAY, EL CAJON CA 92020
David M Theno director 1725 GILLESPIE WAY, EL CAJON CA 92020